MELONIE OWUSU: Open Payments
NPI 1033884002 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 32 payments from 3 companies in 2025. Trend: 2023 $3,535 · 2024 $1,183 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $1,004 |
| ViiV Healthcare Company | 7 | $257 |
| Merck Sharp & Dohme LLC | 2 | $44 |
Products named: Sunlenca, CABENUVA, Yeztugo, PIFELTRO, Biktarvy.
Industry payments across MD — which companies pay providers there.
